Mohammad Eslami vice president and head of the Atomic Energy Organization of Iran (AEOI) was also present in the unveiling ceremony on Saturday.

In the event, the therapeutic radiopharmaceutical ¹⁷⁷Lu-Alpha-MSH for the treatment of metastatic melanoma, the diagnostic radiopharmaceutical ⁶⁸Ga-Alpha-MSH for PET imaging, as well as an automated radiopharmaceutical production machine for the treatment of bone pain caused by cancer metastasis were unveiled. The products that, with their high-level safety and desirable quality, are an effective step in the development of nuclear medicine and the boosting of public health.